Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Oct;51(10):1117–1122. doi: 10.1136/ard.51.10.1117

Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis.

A J Farrell 1, R B Williams 1, C R Stevens 1, A S Lawrie 1, N L Cox 1, D R Blake 1
PMCID: PMC1012415  PMID: 1444624

Abstract

Experimental evidence suggests that rheumatoid synovitis may be perpetuated by the generation of reactive oxygen species during hypoxic reperfusion injury. The latter occurs because increased intra-articular pressure during exercise exceeds synovial capillary perfusion pressure, impairing blood flow. The object of this study was to establish a marker for and the mechanism of synovial hypoxic reperfusion injury. Von Willebrand factor (vWF) is only released from endothelial cells and platelets and is an in vivo and in vitro marker of endothelial injury. In vivo exercise induced changes in plasma vWF were therefore investigated in patients with rheumatoid arthritis (RA) compared with controls and in vitro vWF release by human umbilical vein endothelial cells subjected to hypoxia reperfusion. Pre-exercise plasma vWF levels were 1001 and 817 IU/l, increasing after exercise to 1658 and 845 IU/l in patients with RA and controls respectively. Von Willebrand factor release from human umbilical vein endothelial cells followed a biphasic pattern, occurring during both hypoxia and reperfusion. Hypoxia reperfusion induced vWF release by human umbilical vein endothelial cells in vitro suggests that exercise induced vWF release in patients with RA is best explained by synovial hypoxic reperfusion injury. This study supports evidence that generation of reactive oxygen species plays a principal part in synovial hypoxic reperfusion injury and suggests vWF as a useful marker of this phenomenon.

Full text

PDF
1117

Images in this article

1119Image
on p.1119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen R. E., Blake D. R., Nazhat N. B., Jones P. Superoxide radical generation by inflamed human synovium after hypoxia. Lancet. 1989 Jul 29;2(8657):282–283. doi: 10.1016/s0140-6736(89)90476-5. [DOI] [PubMed] [Google Scholar]
  2. Andrew M., Carter C., O'Brodovich H., Heigenhauser G. Increases in factor VIII complex and fibrinolytic activity are dependent on exercise intensity. J Appl Physiol (1985) 1986 Jun;60(6):1917–1922. doi: 10.1152/jappl.1986.60.6.1917. [DOI] [PubMed] [Google Scholar]
  3. Belch J. J., Zoma A. A., Richards I. M., McLaughlin K., Forbes C. D., Sturrock R. D. Vascular damage and factor-VIII-related antigen in the rheumatic diseases. Rheumatol Int. 1987;7(3):107–111. doi: 10.1007/BF00270462. [DOI] [PubMed] [Google Scholar]
  4. Blake D. R., Merry P., Unsworth J., Kidd B. L., Outhwaite J. M., Ballard R., Morris C. J., Gray L., Lunec J. Hypoxic-reperfusion injury in the inflamed human joint. Lancet. 1989 Feb 11;1(8633):289–293. doi: 10.1016/s0140-6736(89)91305-6. [DOI] [PubMed] [Google Scholar]
  5. Bolli R., Patel B. S., Jeroudi M. O., Lai E. K., McCay P. B. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest. 1988 Aug;82(2):476–485. doi: 10.1172/JCI113621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Geborek P., Forslind K., Wollheim F. A. Direct assessment of synovial blood flow and its relation to induced hydrostatic pressure changes. Ann Rheum Dis. 1989 Apr;48(4):281–286. doi: 10.1136/ard.48.4.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Giustolisi R., Musso R., Cacciola E., Cacciola R. R., Russo M., Petralito A. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction--expression of acute phase reaction or index of vascular endothelium damage? Thromb Haemost. 1984 Jul 29;51(3):408–408. [PubMed] [Google Scholar]
  8. Goetzl E. J., Falchuk K. H., Zeiger L. S., Sullivan A. L., Hebert C. L., Adams J. P., Decker J. L. A physiological approach to the assessment of disease activity in rheumatoid arthritis. J Clin Invest. 1971 Jun;50(6):1167–1180. doi: 10.1172/JCI106594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gralnick H. R., McKeown L. P., Wilson O. M., Williams S. B., Elin R. J. von Willebrand factor release induced by endotoxin. J Lab Clin Med. 1989 Jan;113(1):118–122. [PubMed] [Google Scholar]
  10. Hamilton K. K., Sims P. J. Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1. J Clin Invest. 1987 Feb;79(2):600–608. doi: 10.1172/JCI112853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harkcom T. M., Lampman R. M., Banwell B. F., Castor C. W. Therapeutic value of graded aerobic exercise training in rheumatoid arthritis. Arthritis Rheum. 1985 Jan;28(1):32–39. doi: 10.1002/art.1780280106. [DOI] [PubMed] [Google Scholar]
  12. James M. J., Cleland L. G., Rofe A. M., Leslie A. L. Intraarticular pressure and the relationship between synovial perfusion and metabolic demand. J Rheumatol. 1990 Apr;17(4):521–527. [PubMed] [Google Scholar]
  13. KULKA J. P., BOCKING D., ROPES M. W., BAUER W. Early joint lesions of rheumatoid arthritis; report of eight cases, with knee biopsies of lesions of less than one year's duration. AMA Arch Pathol. 1955 Feb;59(2):129–150. [PubMed] [Google Scholar]
  14. Lafyatis R., Remmers E. F., Roberts A. B., Yocum D. E., Sporn M. B., Wilder R. L. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest. 1989 Apr;83(4):1267–1276. doi: 10.1172/JCI114011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lawrie A. S., Hoser M. J., Savidge G. F. Phast assessment of vWf:Ag multimeric distribution. Thromb Res. 1990 Jul 15;59(2):369–373. doi: 10.1016/0049-3848(90)90139-4. [DOI] [PubMed] [Google Scholar]
  16. Lufkin E. G., Fass D. N., O'Fallon W. M., Bowie E. J. Increased von Willebrand factor in diabetes mellitus. Metabolism. 1979 Jan;28(1):63–66. doi: 10.1016/0026-0495(79)90169-0. [DOI] [PubMed] [Google Scholar]
  17. Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum. 1970 Nov-Dec;13(6):769–776. doi: 10.1002/art.1780130606. [DOI] [PubMed] [Google Scholar]
  18. Lyngberg K., Danneskiold-Samsøe B., Halskov O. The effect of physical training on patients with rheumatoid arthritis: changes in disease activity, muscle strength and aerobic capacity. A clinically controlled minimized cross-over study. Clin Exp Rheumatol. 1988 Jul-Sep;6(3):253–260. [PubMed] [Google Scholar]
  19. Matsubara T., Saura R., Hirohata K., Ziff M. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest. 1989 Jan;83(1):158–167. doi: 10.1172/JCI113853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Matsubara T., Ziff M. Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest. 1987 May;79(5):1440–1446. doi: 10.1172/JCI112972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nilsson J., Elgue G., Wallin M., Hamsten A., Blombck M. Correlation between plasma levels of growth factors and von Willebrand factor. Thromb Res. 1989 Apr 15;54(2):125–132. doi: 10.1016/0049-3848(89)90042-x. [DOI] [PubMed] [Google Scholar]
  22. Patel K. D., Zimmerman G. A., Prescott S. M., McEver R. P., McIntyre T. M. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol. 1991 Feb;112(4):749–759. doi: 10.1083/jcb.112.4.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pottinger B. E., Read R. C., Paleolog E. M., Higgins P. G., Pearson J. D. von Willebrand factor is an acute phase reactant in man. Thromb Res. 1989 Feb 15;53(4):387–394. doi: 10.1016/0049-3848(89)90317-4. [DOI] [PubMed] [Google Scholar]
  24. Remmers E. F., Lafyatis R., Kumkumian G. K., Case J. P., Roberts A. B., Sporn M. B., Wilder R. L. Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Growth Factors. 1990;2(2-3):179–188. [PubMed] [Google Scholar]
  25. Remmers E. F., Sano H., Lafyatis R., Case J. P., Kumkumian G. K., Hla T., Maciag T., Wilder R. L. Production of platelet derived growth factor B chain (PDGF-B/c-sis) mRNA and immunoreactive PDGF B-like polypeptide by rheumatoid synovium: coexpression with heparin binding acidic fibroblast growth factor-1. J Rheumatol. 1991 Jan;18(1):7–13. [PubMed] [Google Scholar]
  26. Richman A. I., Su E. Y., Ho G., Jr Reciprocal relationship of synovial fluid volume and oxygen tension. Arthritis Rheum. 1981 May;24(5):701–705. doi: 10.1002/art.1780240512. [DOI] [PubMed] [Google Scholar]
  27. Robertson A. L., Jr, Khairallah P. A. Arterial endothelial permeability and vascular disease. The "trap door" effect. Exp Mol Pathol. 1973 Apr;18(2):241–260. doi: 10.1016/0014-4800(73)90022-1. [DOI] [PubMed] [Google Scholar]
  28. Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1207–1210. doi: 10.1073/pnas.71.4.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sahinoglu T., Grootveld M., Stevens C. R., Thompson S. J., Claxson A. W., Blake D. R. Influence of disodium aurothiomalate on the activities of xanthine dehydrogenase and xanthine oxidase in endothelial cells. Agents Actions Suppl. 1991;32:71–75. doi: 10.1007/978-3-0348-7405-2_9. [DOI] [PubMed] [Google Scholar]
  30. Short P. E., Williams C. E., Picken A. M., Hill F. G. Factor VIII related antigen: an improved enzyme immunoassay. Med Lab Sci. 1982 Oct;39(4):351–355. [PubMed] [Google Scholar]
  31. Stel H. V., Sakariassen K. S., de Groot P. G., van Mourik J. A., Sixma J. J. Von Willebrand factor in the vessel wall mediates platelet adherence. Blood. 1985 Jan;65(1):85–90. [PubMed] [Google Scholar]
  32. Treuhaft P. S., MCCarty D. J. Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum. 1971 Jul-Aug;14(4):475–484. doi: 10.1002/art.1780140407. [DOI] [PubMed] [Google Scholar]
  33. Warrell R. P., Jr, Hultin M. B., Coller B. S. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure. Am J Med. 1979 Feb;66(2):226–228. doi: 10.1016/0002-9343(79)90531-x. [DOI] [PubMed] [Google Scholar]
  34. Woolf A. D., Wakerley G., Wallington T. B., Scott D. G., Dieppe P. A. Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis. 1987 Jun;46(6):441–447. doi: 10.1136/ard.46.6.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zweier J. L. Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem. 1988 Jan 25;263(3):1353–1357. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES